(Q44733960)

5 December 2017

title

Spotlight on oxcarbazepine in epilepsy (English)

1 reference

5 December 2017

Lynne M Bang

1

1 reference

5 December 2017

Karen L Goa

series ordinal

2

1 reference

5 December 2017

publication date

1 January 2004

1 reference

5 December 2017

1 reference

5 December 2017

volume

18

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

57-61

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200418010-00006

5 December 2017

exact match

0 references

cites work

First dose and steady-state pharmacokinetics of oxcarbazepine and its 10-hydroxy metabolite

1 reference

12 December 2020

Oxcarbazepine in the treatment of early childhood epilepsy

1 reference

12 December 2020

The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites

1 reference

12 December 2020

1 reference

12 December 2020

The distribution of 10-hydroxy carbazepine in blood compartments

1 reference

12 December 2020

The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid

1 reference

12 December 2020

Memory and psychomotor effects of oxcarbazepine in healthy human volunteers

1 reference

12 December 2020

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy

1 reference

12 December 2020

Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders

1 reference

12 December 2020

Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission

1 reference

12 December 2020

Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal) on a named-patient basis

1 reference

12 December 2020

Cognitive function and anticonvulsant therapy: effect of monotherapy in epilepsy

1 reference

12 December 2020

The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy.

1 reference

12 December 2020

Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures.

1 reference

12 December 2020

A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients

1 reference

12 December 2020

Pharmacological management of epilepsy. Mechanism of action, pharmacokinetic drug interactions, and new drug discovery possibilities.

1 reference

12 December 2020

Oxcarbazepine and hyponatremia

1 reference

12 December 2020

Oxcarbazepine: current status and clinical applications

1 reference

12 December 2020

Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects

1 reference

12 December 2020

Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group

1 reference

12 December 2020

Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents

1 reference

12 December 2020

10.2165/00023210-200418010-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

5 December 2017

1030868304

0 references

1 reference